Securities Code: 002390 Securities Abbreviation: Xinbang Pharmaceutical Announcement No.: 2026-012
Guizhou Xinbang Pharmaceutical Co., Ltd. Announcement on the Provision of Asset Impairment Provisions for 2025
The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and there is no false record, misleading statement, or major omission.
Guizhou Xinbang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") deliberated and passed the "Proposal on the Provision of Asset Impairment Provisions for 2025" at the tenth meeting of the ninth Board of Directors held on April 17, 2026. The matter is hereby announced as follows:
I. Situation of the Company's Provision for Asset Impairment Losses This Time
(I) Credit Impairment Loss Situation